 ValuEngine upgraded shares of Applied Therapeutics NASDAQ:APLT from a hold rating to a buy rating in a report released on Thursday, ValuEngine reports. A number of other equities analysts also recently issued reports on the company. Citigroup raised their price objective on Applied Therapeutics from 29.00 to 44.00 and gave the stock a buy rating ... 